|
1
|
Perucca E, French J and Bialer M:
Development of new antiepileptic drugs: Challenges, incentives, and
recent advances. Lancet Neurol. 6:793–804. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Aronica E, Becker AJ and Spreafico R:
Malformations of cortical development. Brain Pathol. 22:380–401.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vezzani A, Conti M, De Luigi A, Ravizza T,
Moneta D, Marchesi F and De Simoni MG: Interleukin-1beta
immunoreactivity and microglia are enhanced in the rat hippocampus
by focal kainate application: Functional evidence for enhancement
of electrographic seizures. J Neurosci. 19:5054–5065.
1999.PubMed/NCBI
|
|
4
|
van Scheppingen J, Broekaart DW, Scholl T,
Zuidberg MR, Anink JJ, Spliet WG, van Rijen PC, Czech T,
Hainfellner JA, Feucht M, et al: Dysregulation of the
(immuno)proteasome pathway in malformations of cortical
development. J Neuroinflammation. 13:2022016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Aronica E and Crino PB: Inflammation in
epilepsy: Clinical observations. Epilepsia. 3 52 Suppl:S26–S32.
2011. View Article : Google Scholar
|
|
6
|
Zurolo E, Iyer A, Maroso M, Carbonell C,
Anink JJ, Ravizza T, Fluiter K, Spliet WG, van Rijen PC, Vezzani A
and Aronica E: Activation of Toll-like receptor, RAGE and HMGB1
signalling in malformations of cortical development. Brain.
134:1015–1032. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Boer K, Jansen F, Nellist M, Redeker S,
van den Ouweland AM, Spliet WG, van Nieuwenhuizen O, Troost D,
Crino PB and Aronica E: Inflammatory processes in cortical tubers
and subependymal giant cell tumors of tuberous sclerosis complex.
Epilepsy Res. 78:7–21. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Maroso M, Balosso S, Ravizza T, Liu J,
Aronica E, Iyer AM, Rossetti C, Molteni M, Casalgrandi M, Manfredi
AA, et al: Toll-like receptor 4 and high-mobility group box-1 are
involved in ictogenesis and can be targeted to reduce seizures. Nat
Med. 16:413–419. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chiavegato A, Zurolo E, Losi G, Aronica E
and Carmignoto G: The inflammatory molecules IL-1β and HMGB1 can
rapidly enhance focal seizure generation in a brain slice model of
temporal lobe epilepsy. Front Cell Neurosci. 8:1552014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chenard BL and Menniti FS: Antagonists
selective for NMDA receptors containing the NR2B subunit. Curr
Pharm Des. 5:381–404. 1999.PubMed/NCBI
|
|
11
|
Fisher RS, Cross JH, D'Souza C, French JA,
Haut SR, Higurashi N, Hirsch E, Jansen FE, Lagae L, Moshé SL, et
al: Instruction manual for the ILAE 2017 operational classification
of seizure types. Epilepsia. 58:531–542. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hemb M, Velasco TR, Parnes MS, Wu JY,
Lerner JT, Matsumoto JH, Yudovin S, Shields WD, Sankar R, Salamon
N, et al: Improved outcomes in pediatric epilepsy surgery: The UCLA
experience, 1986–2008. Neurology. 74:1768–1775. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hoffman WH and Haberly LB:
Bursting-induced epileptiform EPSPs in slices of piriform cortex
are generated by deep cells. J Neurosci. 11:2021–2031.
1991.PubMed/NCBI
|
|
14
|
Hoffman WH and Haberly LB: Bursting
induces persistent all-or-none EPSPs by an NMDA-dependent process
in piriform cortex. J Neurosci. 9:206–215. 1989.PubMed/NCBI
|
|
15
|
Wang B, Yin L, Zou X, Ye M, Liu Y, He T,
Deng S, Jiang Y, Zheng R, Wang Y, et al: A Subtype of inhibitory
interneuron with intrinsic persistent activity in human and monkey
neocortex. Cell Rep. Mar 3–2015.(Epub ahead of print).
|
|
16
|
Viviani B, Bartesaghi S, Gardoni F,
Vezzani A, Behrens MM, Bartfai T, Binaglia M, Corsini E, Di Luca M,
Galli CL and Marinovich M: Interleukin-1beta enhances NMDA
receptor-mediated intracellular calcium increase through activation
of the Src family of kinases. J Neurosci. 23:8692–8700.
2003.PubMed/NCBI
|
|
17
|
Geiger JR and Jonas P: Dynamic control of
presynaptic Ca(2+) inflow by fast-inactivating K(+) channels in
hippocampal mossy fiber boutons. Neuron. 28:927–939. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Connors BW, Gutnick MJ and Prince DA:
Electrophysiological properties of neocortical neurons in vitro. J
Neurophysiol. 48:1302–1320. 1982.PubMed/NCBI
|
|
19
|
Lotze MT and Tracey KJ: High-mobility
group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal.
Nat Rev Immunol. 5:331–342. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang L, Zhang X, Liu L, Cui L, Yang R, Li
M and Du W: Tanshinone II A down-regulates HMGB1, RAGE, TLR4,
NF-kappaB expression, ameliorates BBB permeability and endothelial
cell function, and protects rat brains against focal ischemia.
Brain Res. 1321:143–151. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang R, Lao L, Ren K and Berman BM:
Mechanisms of acupuncture-electroacupuncture on persistent pain.
Anesthesiology. 120:482–503. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bianchi ME and Manfredi AA: Immunology.
Dangers in and out. Science. 323:1683–1684. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bianchi ME: DAMPs, PAMPs and alarmins: All
we need to know about danger. J Leukoc Biol. 81:1–5. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Catterall WA: Structure and regulation of
voltage-gated Ca2+ channels. Annu Rev Cell Dev Biol. 16:521–555.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huttunen HJ and Rauvala H: Amphoterin as
an extracellular regulator of cell motility: From discovery to
disease. J Intern Med. 255:351–366. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pedrazzi M, Patrone M, Passalacqua M,
Ranzato E, Colamassaro D, Sparatore B, Pontremoli S and Melloni E:
Selective proinflammatory activation of astrocytes by high-mobility
group box 1 protein signaling. J Immunol. 179:8525–8532. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Najm IM, Ying Z, Babb T, Mohamed A, Hadam
J, LaPresto E, Wyllie E, Kotagal P, Bingaman W and Foldvary N:
Epileptogenicity correlated with increased N-methyl-D-aspartate
receptor subunit NR2A/B in human focal cortical dysplasia.
Epilepsia. 41:971–976. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Thomas CG, Miller AJ and Westbrook GL:
Synaptic and extrasynaptic NMDA receptor NR2 subunits in cultured
hippocampal neurons. J Neurophysiol. 95:1727–1734. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Botta P, Demmou L, Kasugai Y, Markovic M,
Xu C, Fadok JP, Lu T, Poe MM, Xu L, Cook JM, et al: Regulating
anxiety with extrasynaptic inhibition. Nat Neurosci. 18:1493–1500.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Waters J and Helmchen F: Background
synaptic activity is sparse in neocortex. J Neurosci. 26:8267–8277.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bean BP: The action potential in mammalian
central neurons. Nat Rev Neurosci. 8:451–465. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gardoni F, Boraso M, Zianni E, Corsini E,
Galli CL, Cattabeni F, Marinovich M, Di Luca M and Viviani B:
Distribution of interleukin-1 receptor complex at the synaptic
membrane driven by interleukin-1β and NMDA stimulation. J
Neuroinflammation. 8:142011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
García-Arnandis I, Guillén MI, Gomar F,
Pelletier JP, Martel-Pelletier J and Alcaraz MJ: High mobility
group box 1 potentiates the pro-inflammatory effects of
interleukin-1β in osteoarthritic synoviocytes. Arthritis Res Ther.
12:R1652010. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Howard P, Twycross R, Shuster J, Mihalyo
M, Rémi J and Wilcock A: Anti-epileptic drugs. J Pain Symptom
Manage. 42:788–804. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Neels HM, Sierens AC, Naelaerts K, Scharpé
SL, Hatfield GM and Lambert WE: Therapeutic drug monitoring of old
and newer anti-epileptic drugs. Clin Chem Lab Med. 42:1228–1255.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
O'Neill LA and Bowie AG: The family of
five: TIR-domain-containing adaptors in toll-like receptor
signalling. Nat Rev Immunol. 7:353–364. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang CX and Shuaib A: NMDA/NR2B selective
antagonists in the treatment of ischemic brain injury. Curr Drug
Targets CNS Neurol Disord. 4:143–151. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tu W, Xu X, Peng L, Zhong X, Zhang W,
Soundarapandian MM, Balel C, Wang M, Jia N, Zhang W, et al: DAPK1
interaction with NMDA receptor NR2B subunits mediates brain damage
in stroke. Cell. 140:222–234. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Perin-Dureau F, Rachline J, Neyton J and
Paoletti P: Mapping the binding site of the neuroprotectant
ifenprodil on NMDA receptors. J Neurosci. 22:5955–5965.
2002.PubMed/NCBI
|
